Manhattan Scientifics Inc (MHTX)

[nupapa]

MHTX NEW RESEARCH - PRICE TARGET .22
http://smallcaptraders.com/wp-content/uploads/2014/07/MHTX-MA-BB-SCT.pdf

July 1, 2014
Michael Anderegg, CFA
Senior Research Analyst [e-mail]

Summary and Investment Thesis

Manhattan Scientifics Inc. (www.mhtx.com) is located in New Mexico, New York and Montreal. It is focused on technology transfer and commercialization of disruptive technologies in the nanomedicine space. The company is presently developing commercial medical prosthetics applications for its ultrafine grain metals and plans to commercialize the cancer research work and nanomedical applications developed by Senior Scientific LLC, a unit of the Company.

Manhattan Scientifics distinguishes itself from other incubators or venture capital firms in that it uses its own, rather than managed capital. Consequently, Manhattan Scientifics’ actions are not constrained by preset rules and fund-life-time tables, and the technologist avoids many of the sometimes-adversarial aspects of venture capital relationships. Technologists who are “partnered” with the Company also enjoy the diversity of shared success with their brother technologists at Manhattan Scientifics - success at any one of the Company’s technologies finds its way into the value of the equity, and that success is shared by the entrepreneur whose concept or acceptance in the market place has not yet matured. Manhattan Scientifics brings its expertise with capital, but also with talent including IP counsel, experienced marketers and networkers with global reach.

We are issuing a Research Update on MHTX based on recent developments including delivery of its break-through, cancer measurement instrument to The University of Texas M.D. Anderson Cancer Center and a relationship with Los Alamos National Laboratory. If the Company’s underlying patents can be advanced into viable commercial applications the portfolio could ultimately generate a sustainable revenue stream going forward. We rate the shares Equal Weight/Hold with a technical price target of $0.22.

Likely durable support is in the $0.1035 - $0.1070 range. A standard 61.8% retracement equates to $0.1069. As long as the trendline slightly below that level holds the trend remains up.

Resistance appears near $.1795 and then our rally continuation breakout target of $0.22.